Chimerix Inc. (NASDAQ: CMRX)
$0.95
+0.0117 ( +1.25% ) 524.5K
Chimerix Inc. is a biopharmaceutical company based in the United States that engages in the research, development, and commercialization of medicines. Its portfolio includes treatment for acute myeloid leukemia (or AML) and antiviral treatment for smallpox. The company generates revenue through revenue related to non-refundable upfront fees, royalties and milestone payments earned under license agreements, also by royalty revenue related to sales of TEMBEXA made by Emergent after the Asset Sale. The company operates only in one business segment namely pharmaceuticals.
Market Data
Open
$0.95
Previous close
$0.94
Volume
524.5K
Market cap
$84.92M
Day range
$0.91 - $0.98
52 week range
$0.78 - $1.30
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Dec 04, 2023 |
3 | Insider transactions | 2 | Dec 04, 2023 |
8-k | 8K-related | 18 | Dec 04, 2023 |
4 | Insider transactions | 1 | Nov 20, 2023 |
8-k | 8K-related | 16 | Nov 16, 2023 |
3 | Insider transactions | 2 | Nov 16, 2023 |
4 | Insider transactions | 1 | Nov 16, 2023 |
4 | Insider transactions | 1 | Nov 13, 2023 |
8-k | 8K-related | 57 | Nov 02, 2023 |
10-q | Quarterly Reports | 60 | Nov 02, 2023 |